Puttaraju; Madaiah

Patent Applications and Registrations

Patent applications and USPTO patent grants for Puttaraju; Madaiah.The latest application filed is for "compositions and methods for modulation of lmna expression".

Company Profile

0.5.18

Puttaraju; Madaiah - Bethesda MD
Puttaraju; Madaiah - Germantown MD
Puttaraju; Madaiah - Durham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Modulation Of Lmna Expression App 20220031731 - Singh; Priyam ; et al.	2022-02-03
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Grant 8,883,753 - Puttaraju , et al. November 11, 2	2014-11-11
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing Grant 8,053,232 - Puttaraju , et al. November 8, 2	2011-11-08
Compositions And Methods For Generation Of Pluripotent Stem Cells App 20110263015 - D'Costa; Jenice G. ; et al.	2011-10-27
Use Of Rna Trans-splicing For Antibody Gene Transfer And Antibody Polypeptide Production App 20110244519 - McGarrity; Gerard J. ; et al.	2011-10-06
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Grant 7,968,334 - Puttaraju , et al. June 28, 2	2011-06-28
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production Grant 7,879,321 - McGarrity , et al. February 1, 2	2011-02-01
Methods and compositions for use in spliceosome mediated RNA trans-splicing App 20060246422 - Mitchell; Lloyd G. ; et al.	2006-11-02
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing App 20060234247 - Puttaraju; Madaiah ; et al.	2006-10-19
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing App 20060194317 - Puttaraju; Madaiah ; et al.	2006-08-31
Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing App 20060177933 - Puttaraju; Madaiah ; et al.	2006-08-10
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production App 20060160182 - McGarrity; Gerard J. ; et al.	2006-07-20
Screening method for identification of efficient pre-trans-splicing molecules App 20060154257 - Mitchell; Lloyd G. ; et al.	2006-07-13
Spliceosome mediated RNA trans-splicing for correction of skin disorders App 20040248141 - Mitchell, Lloyd G. ; et al.	2004-12-09
Spliceosome mediated RNA trans-splicing App 20040214263 - Mitchell, Lloyd G. ; et al.	2004-10-28
Spliceosome mediated RNA trans-splicing for correction of skin disorders App 20040018622 - Mitchell, Lloyd G. ; et al.	2004-01-29
Transgenic animal model for spliceosome-mediated RNA trans-splicing App 20030204861 - Puttaraju, Madaiah ; et al.	2003-10-30
Methods and compositions for use in spliceosome mediated RNA trans-splicing App 20030153054 - Mitchell, Lloyd G. ; et al.	2003-08-14
Methods and compositions for use in spliceosome mediated RNA trans-splicing App 20030077754 - Mitchell, Lloyd G. ; et al.	2003-04-24
Methods and compositions for use in spliceosome mediated RNA trans-splicing App 20030027250 - Mitchell, Lloyd G. ; et al.	2003-02-06
Methods and compositions for use in spliceosome mediated RNA trans-splicing App 20020193580 - Mitchell, Lloyd G. ; et al.	2002-12-19
Methods and compositions for use in spliceosome mediated RNA trans-splicing App 20020115207 - Mitchell, Lloyd G. ; et al.	2002-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.